Logo image of NHC

NATIONAL HEALTHCARE CORP (NHC) Stock Fundamental Analysis

USA - NYSE Arca - NYSEARCA:NHC - US6359061008 - Common Stock

138.57 USD
+0.82 (+0.6%)
Last: 12/12/2025, 8:04:00 PM
138.57 USD
0 (0%)
After Hours: 12/12/2025, 8:04:00 PM
Fundamental Rating

6

Taking everything into account, NHC scores 6 out of 10 in our fundamental rating. NHC was compared to 100 industry peers in the Health Care Providers & Services industry. NHC scores excellent on profitability, but there are some minor concerns on its financial health. NHC is valued correctly, but it does not seem to be growing. Finally NHC also has an excellent dividend rating. With these ratings, NHC could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year NHC was profitable.
In the past year NHC had a positive cash flow from operations.
In the past 5 years NHC has always been profitable.
In the past 5 years NHC always reported a positive cash flow from operatings.
NHC Yearly Net Income VS EBIT VS OCF VS FCFNHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

NHC has a better Return On Assets (6.71%) than 87.00% of its industry peers.
NHC's Return On Equity of 10.26% is fine compared to the rest of the industry. NHC outperforms 74.00% of its industry peers.
NHC has a Return On Invested Capital of 6.69%. This is in the better half of the industry: NHC outperforms 66.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NHC is significantly below the industry average of 9.44%.
The 3 year average ROIC (3.68%) for NHC is below the current ROIC(6.69%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.71%
ROE 10.26%
ROIC 6.69%
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
NHC Yearly ROA, ROE, ROICNHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With an excellent Profit Margin value of 7.19%, NHC belongs to the best of the industry, outperforming 86.00% of the companies in the same industry.
In the last couple of years the Profit Margin of NHC has grown nicely.
NHC's Operating Margin of 7.99% is fine compared to the rest of the industry. NHC outperforms 74.00% of its industry peers.
NHC's Operating Margin has improved in the last couple of years.
The Gross Margin of NHC (38.11%) is better than 67.00% of its industry peers.
In the last couple of years the Gross Margin of NHC has remained more or less at the same level.
Industry RankSector Rank
OM 7.99%
PM (TTM) 7.19%
GM 38.11%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
NHC Yearly Profit, Operating, Gross MarginsNHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

NHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, NHC has more shares outstanding
NHC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NHC has a worse debt to assets ratio.
NHC Yearly Shares OutstandingNHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
NHC Yearly Total Debt VS Total AssetsNHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

NHC has an Altman-Z score of 4.41. This indicates that NHC is financially healthy and has little risk of bankruptcy at the moment.
NHC's Altman-Z score of 4.41 is fine compared to the rest of the industry. NHC outperforms 79.00% of its industry peers.
NHC has a debt to FCF ratio of 0.93. This is a very positive value and a sign of high solvency as it would only need 0.93 years to pay back of all of its debts.
The Debt to FCF ratio of NHC (0.93) is better than 91.00% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that NHC is not too dependend on debt financing.
NHC's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. NHC outperforms 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.93
Altman-Z 4.41
ROIC/WACC0.77
WACC8.72%
NHC Yearly LT Debt VS Equity VS FCFNHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.72 indicates that NHC should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.72, NHC is doing good in the industry, outperforming 68.00% of the companies in the same industry.
A Quick Ratio of 1.69 indicates that NHC should not have too much problems paying its short term obligations.
NHC has a Quick ratio of 1.69. This is in the better half of the industry: NHC outperforms 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.69
NHC Yearly Current Assets VS Current LiabilitesNHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.19% over the past year.
The Earnings Per Share has been growing by 8.03% on average over the past years. This is quite good.
The Revenue has grown by 22.82% in the past year. This is a very strong growth!
NHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.58% yearly.
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NHC Yearly Revenue VS EstimatesNHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.65, which indicates a rather expensive current valuation of NHC.
NHC's Price/Earnings ratio is a bit cheaper when compared to the industry. NHC is cheaper than 71.00% of the companies in the same industry.
NHC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.54.
Industry RankSector Rank
PE 20.65
Fwd PE N/A
NHC Price Earnings VS Forward Price EarningsNHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

NHC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NHC is cheaper than 68.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, NHC is valued a bit cheaper than the industry average as 69.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.08
EV/EBITDA 11.48
NHC Per share dataNHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The excellent profitability rating of NHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.57
EPS Next 2YN/A
EPS Next 3YN/A

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.86%, NHC has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.44, NHC pays a better dividend. On top of this NHC pays more dividend than 91.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, NHC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.86%

5.2 History

The dividend of NHC has a limited annual growth rate of 3.30%.
NHC has paid a dividend for at least 10 years, which is a reliable track record.
NHC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.3%
Div Incr Years11
Div Non Decr Years11
NHC Yearly Dividends per shareNHC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

NHC pays out 35.96% of its income as dividend. This is a sustainable payout ratio.
NHC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP35.96%
EPS Next 2YN/A
EPS Next 3YN/A
NHC Yearly Income VS Free CF VS DividendNHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M
NHC Dividend Payout.NHC Dividend Payout, showing the Payout Ratio.NHC Dividend Payout.PayoutRetained Earnings

NATIONAL HEALTHCARE CORP

NYSEARCA:NHC (12/12/2025, 8:04:00 PM)

After market: 138.57 0 (0%)

138.57

+0.82 (+0.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-31 2025-10-31
Earnings (Next)02-25 2026-02-25
Inst Owners62.45%
Inst Owner Change5.58%
Ins Owners7.08%
Ins Owner Change0.24%
Market Cap2.15B
Revenue(TTM)1.46B
Net Income(TTM)104.80M
Analysts60
Price TargetN/A
Short Float %2.42%
Short Ratio4.43
Dividend
Industry RankSector Rank
Dividend Yield 1.86%
Yearly Dividend2.4
Dividend Growth(5Y)3.3%
DP35.96%
Div Incr Years11
Div Non Decr Years11
Ex-Date12-31 2025-12-31 (0.64)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.65
Fwd PE N/A
P/S 1.47
P/FCF 18.08
P/OCF 14.43
P/B 2.1
P/tB 2.59
EV/EBITDA 11.48
EPS(TTM)6.71
EY4.84%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)7.66
FCFY5.53%
OCF(TTM)9.61
OCFY6.93%
SpS93.95
BVpS65.84
TBVpS53.58
PEG (NY)N/A
PEG (5Y)2.57
Graham Number99.7
Profitability
Industry RankSector Rank
ROA 6.71%
ROE 10.26%
ROCE 9.01%
ROIC 6.69%
ROICexc 8.35%
ROICexgc 10.23%
OM 7.99%
PM (TTM) 7.19%
GM 38.11%
FCFM 8.16%
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
ROICexc(3y)4.49%
ROICexc(5y)5.97%
ROICexgc(3y)5.54%
ROICexgc(5y)6.99%
ROCE(3y)4.96%
ROCE(5y)6.21%
ROICexgc growth 3Y-4%
ROICexgc growth 5Y11.11%
ROICexc growth 3Y-3.17%
ROICexc growth 5Y7.37%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
F-Score4
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.93
Debt/EBITDA 0.64
Cap/Depr 68.45%
Cap/Sales 2.07%
Interest Coverage 250
Cash Conversion 92.81%
Profit Quality 113.47%
Current Ratio 1.72
Quick Ratio 1.69
Altman-Z 4.41
F-Score4
WACC8.72%
ROIC/WACC0.77
Cap/Depr(3y)68.9%
Cap/Depr(5y)71.13%
Cap/Sales(3y)2.45%
Cap/Sales(5y)2.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.08%
EBIT growth 3Y3.3%
EBIT growth 5Y11.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y219.85%
FCF growth 3Y51.34%
FCF growth 5Y1.58%
OCF growth 1Y136.11%
OCF growth 3Y19.81%
OCF growth 5Y1.4%

NATIONAL HEALTHCARE CORP / NHC FAQ

What is the fundamental rating for NHC stock?

ChartMill assigns a fundamental rating of 6 / 10 to NHC.


What is the valuation status of NATIONAL HEALTHCARE CORP (NHC) stock?

ChartMill assigns a valuation rating of 4 / 10 to NATIONAL HEALTHCARE CORP (NHC). This can be considered as Fairly Valued.


How profitable is NATIONAL HEALTHCARE CORP (NHC) stock?

NATIONAL HEALTHCARE CORP (NHC) has a profitability rating of 8 / 10.


What are the PE and PB ratios of NATIONAL HEALTHCARE CORP (NHC) stock?

The Price/Earnings (PE) ratio for NATIONAL HEALTHCARE CORP (NHC) is 20.65 and the Price/Book (PB) ratio is 2.1.


How sustainable is the dividend of NATIONAL HEALTHCARE CORP (NHC) stock?

The dividend rating of NATIONAL HEALTHCARE CORP (NHC) is 7 / 10 and the dividend payout ratio is 35.96%.